← Open Payments lookup

MEGAN MCGOEY: Open Payments

NPI 1679933287 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,024 in 27 payments from 11 companies in 2025. Trend: 2023 $1,281 · 2024 $1,033 · 2025 $1,024

Food & beverage: $1,024
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP4$340
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$265
Teva Pharmaceuticals USA, Inc.9$141
ABBVIE INC.1$112
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$42
Otsuka America Pharmaceutical, Inc.2$34
Phathom Pharmaceuticals, Inc.1$21
Lilly USA, LLC1$19
Otsuka Pharmaceutical Development & Commercialization, Inc.1$18
Lundbeck LLC1$18

Products named: CAPLYTA, AIRSUPRA, AUSTEDO XR, VRAYLAR, FARXIGA, REXULTI, XIFAXAN, VOQUEZNA.

Industry payments across LA — which companies pay providers there.